Question 1

Does Goldman Sachs own ABEO stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Goldman Sachs holds 1,224,806 shares of ABEO (Abeona Therapeutics), worth $7.6M.

Question 2

How many shares of ABEO does Goldman Sachs own?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs holds 1,224,806 shares of ABEO (Abeona Therapeutics).

Question 3

What is Goldman Sachs' ABEO position worth?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs' ABEO position is worth $7.6M.

Question 4

Is Goldman Sachs buying or selling ABEO?

Accepted Answer

In Q2 2026, Goldman Sachs increased its ABEO position by 94,187 shares (+8.3%).

Question 5

When did Goldman Sachs first buy ABEO?

Accepted Answer

Goldman Sachs first reported ABEO in its Q4 2022 13F and has listed it in 11 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1.2M	+8.3%	$7.6M	0.0%	$6.18	30
2026-Q1	Increased	1.1M	+125.1%	$5.1M	0.0%	$4.48	43
2025-Q4	Increased	502,184	+55.8%	$2.6M	0.0%	$5.27	37
2025-Q3	Increased	322,431	+135.1%	$1.7M	0.0%	$5.28	41
2025-Q2	Decreased	137,146	-31.6%	$778,989	0.0%	$5.68	0
2025-Q1	Increased	200,450	+49.6%	$954,142	0.0%	$4.76	35
2024-Q4	New	134,028	-	$746,536	0.0%	$5.57	34

ABEOShowing 7 of 13 quarters

ABEO
Showing 7 of 13 quarters